Sarepta Therapeutics (SRPT) Inventory (2016 - 2026)

Sarepta Therapeutics' Inventory history runs 11 years deep, the most recent figure standing at $1.0 billion for Q1 2026.

• In Q1 2026, Inventory rose 6.34% year-over-year to $1.0 billion; the TTM figure through Mar 2026 stood at $1.0 billion (up 6.34% YoY), while the FY2025 annual figure was $914.7 million, up 21.97% from the prior year.
• Inventory was $1.0 billion for Q1 2026 at Sarepta Therapeutics, up from $914.7 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $1.1 billion in Q3 2025 to a low of $199.0 million in Q1 2022.
• Historically, Inventory has averaged $525.4 million across 5 years, with a median of $373.5 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Inventory retreated 23.32% in 2022, then surged 152.04% in 2025.
• A 5-year view of Inventory shows it stood at $204.0 million in 2022, then surged by 58.29% to $322.9 million in 2023, then jumped by 132.29% to $750.0 million in 2024, then increased by 21.97% to $914.7 million in 2025, then climbed by 9.44% to $1.0 billion in 2026.
• The last three Inventory figures came in at $1.0 billion (Q1 2026), $914.7 million (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.